Accent Therapeutics
PrivateLast Round
Series C
Jan 23, 2024
Total Funding Raised
$178M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Accent Therapeutics is a biopharmaceutical company that develops small molecule precision oncology therapies targeting RNA-modifying proteins.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Accent Therapeutics Comparables
Compare Accent Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| EPICS Therapeutics | 86% | |
| STORM Therapeutics | 85% | |
| Remix Therapeutics | 84% | |
Accent Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Jan 23, 2024 | ||||
| Series B | Apr 23, 2020 | ||||
| Series A | Sep 18, 2017 |
Accent Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| EcoR1 Capital | Series C, Series A, Series B |
| The Column Group | Series A, Series B, Series C |
| GV | Series B, Series C |
| Mirae Asset | Series C |
| Droia Ventures | Series B, Series C |
| The Chernin Group | Series B, Series C, Series A |
| AbbVie Ventures | Series B, Series C |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 24, 2026
Monthly visitors increased 48% MoM.
- Apr 17, 2026
New data for KIF18A inhibitor ATX-295 presented at AACR Annual Meeting.
Accent Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Accent Therapeutics's valuation, stock price, and market status.